L. Pollack
Clinical Infectious Diseases · 2014
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom L. Pollack trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from L. Pollack's perspective
Ordered by how strongly the researchers L. Pollack trusts endorse each paper. Same corpus, a different order for every researcher.
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. (Clinical Infectious Diseases)
- A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. (Journal of the American Medical Association (JAMA))
- High rates of adverse drug events in a highly computerized hospital. (Archives of Internal Medicine)
- Computer Physician Order Entry: Benefits, Costs, and Issues (Annals of Internal Medicine)
- Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
- Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. (Clinical Infectious Diseases)
- Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (Clinical Infectious Diseases)
- The impact of antimicrobial resistance on health and economic outcomes. (Clinical Infectious Diseases)
- Computer technology and clinical work: still waiting for Godot. (Journal of the American Medical Association (JAMA))
- The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. (Clinical Infectious Diseases)